Lagevrio Coupons & Discount Card – Guaranteed Prices from $1.01
My prescription
Edit
200MG, Lagevrio (30 Capsules)
Select pharmacy
CVS
$719.10
COUPON PRICE
Walmart
$1.01
COUPON PRICE
Rite Aid
$735.92
COUPON PRICE
Walgreens
$768.32
COUPON PRICELagevrio savings card
Show this card to your pharmacistWalmart
$1.01
BIN
ID
PCN
GRP
019876
LHCA728CB7
CHIPPO
LHX
Powered by
Related nucleoside analogue antivirals prescriptions
More prescriptions for COVID-19
Related nucleoside analogue antivirals prescriptions
More prescriptions for COVID-19
Lagevrio dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 200MG | 30 Capsules | $1.01 | $0.03 |
Lagevrio Warnings
This medication comes with several important safety warnings, which you should carefully review. If you have any concerns or questions, please consult your healthcare provider.
Risk of Birth Defects: There is a potential risk for birth defects in infants born to mothers who use Lagevrio (molnupiravir) during pregnancy. To mitigate this risk, a pregnancy test may be recommended before initiating treatment. In some cases, the benefits of using Lagevrio during pregnancy may outweigh the risks. If you choose to proceed with this treatment while pregnant, participation in the COVID-19 International Pregnancy Registry is highly encouraged.
Bone and Cartilage Damage: This medication is not suitable for individuals under 18 years of age due to the risk of bone and cartilage damage. If you experience symptoms such as joint or bone pain, swelling, or a clicking or grinding sensation in the joints, inform your healthcare provider immediately.
Serious Allergic Reactions: Although rare, some individuals may experience serious allergic reactions to Lagevrio (molnupiravir). Seek immediate medical attention if you notice any symptoms of anaphylaxis, such as facial swelling, difficulty breathing, or hives.
There are no known contraindications for this medication at present. Always discuss any concerns or medical conditions with your healthcare provider before starting any new medication.
Lagevrio Side Effects
When taking this medication, you may experience some mild side effects, including diarrhea, nausea, and dizziness. These symptoms are generally not serious and may subside as your body adjusts to the medication. However, if these effects persist or worsen, it's important to inform your healthcare provider to ensure proper management.
On rare occasions, some individuals may experience serious allergic reactions to this drug. Symptoms of such a reaction can include a rash, itching, swelling (particularly of the face, tongue, or throat), severe dizziness, and trouble breathing. These symptoms require immediate medical attention to prevent complications.
It's crucial to note that while these side effects have been reported, the full range of possible side effects is not completely known at this time. Always communicate any unusual symptoms to your healthcare provider to ensure your safety while using this medication.
Lagevrio Interactions
What is the drug Lagevrio used for?
Lagevrio is used for the treatment of mild to moderate COVID-19 in adults who are at high risk for progressing to severe disease, including hospitalization or death.
Is lagevrio better than Paxlovid?
The effectiveness of Lagevrio (molnupiravir) versus Paxlovid (nirmatrelvir/ritonavir) can vary depending on individual patient circumstances, including the severity of the COVID-19 infection, underlying health conditions, and potential drug interactions. Paxlovid has generally shown higher efficacy in reducing the risk of hospitalization and death in clinical trials compared to Lagevrio. However, the choice between these medications should be made by a healthcare provider, who can consider the specific needs and medical history of the patient.
What is the downside of taking Lagevrio?
Lagevrio, also known as molnupiravir, may have several potential downsides or side effects. Common side effects include diarrhea, nausea, and dizziness. There is also a concern about its potential to cause mutations, which could theoretically lead to long-term effects, although this risk is still being studied. Additionally, it is not recommended for use during pregnancy due to potential risks to the fetus. As with any medication, it is important to discuss potential risks and benefits with a healthcare provider.
How effective is lagevrio in treating COVID?
Lagevrio (molnupiravir) has been shown to be effective in reducing the risk of hospitalization and death in patients with mild to moderate COVID-19 who are at high risk for severe disease. Clinical trials have demonstrated that it can decrease the likelihood of progression to severe illness when administered early in the course of the infection. However, its effectiveness may vary based on individual patient factors and the specific variant of the virus. It is important for patients to consult with their healthcare provider to determine if Lagevrio is an appropriate treatment option for their situation.
Who shouldn't take molnupiravir?
Molnupiravir should not be taken by individuals who are allergic to any of its components. It is also not recommended for use in pregnant women due to potential risks to the fetus. Additionally, it should be used with caution in breastfeeding women, and they should consult their healthcare provider before use. Molnupiravir is not authorized for use in patients under 18 years of age. It is important for individuals to discuss their medical history and current medications with their healthcare provider before starting molnupiravir.